By Amira McKee

Chemours posted a wider fourth-quarter loss and a slip in revenue, driven by volume declines in its titanium technologies and advanced performance materials businesses.

The Wilmington, Del., chemicals company had a loss of $47 million, or 31 cents a share, compared with a loss of $11 million, or 8 cents a share, a year earlier.

Adjusted earnings came in at 5 cents a share, missing the 7 cents that analysts were expecting, according to FactSet.

Chemours said the wider loss was driven by lower cost absorption related to production declines across its titanium technologies and advanced performance materials segments. A non-cash inventory charge and unfavorable product mix in advanced performance materials, and a higher provision for income taxes also impacted the results, the company said.

Sales fell 2% to $1.33 billion, in line with the expectations of analysts polled by FactSet. Chemours attributed the top-line results to a 4% decline in volume, partially offset by 1% increases in price and currency tailwind.

The volume decline was primarily driven by weaker cyclically-sensitive end markets impacting both its titanium technologies and advanced performance materials businesses, the company said. The impacts were partially offset by continued strength in thermal and specialized solutions volume tied to a boost in Opteon refrigerants adoption.

For 2026, Chemours expects sales growth of 3 to 5%. Wall Street is anticipating sales of $6.04 billion, according to FactSet. That estimate represents around 4.1% growth compared to 2025.

The company guided for full-year adjusted earnings before interest, taxes, depreciation, and amortization between $800 million and $900 million. Analysts polled by FactSet forecast $878.6 million.

Write to Amira McKee at amira.mckee@wsj.com

(END) Dow Jones Newswires

February 19, 2026 17:16 ET (22:16 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.